摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5,7-di-2-thienyl-2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione | 1415304-05-0

中文名称
——
中文别名
——
英文名称
5,7-di-2-thienyl-2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione
英文别名
5,7-Di(thiophen-2-yl)-2,3-dihydro-1h-pyrrolo[3,4-d]pyridazine-1,4(6h)-dione;5,7-dithiophen-2-yl-3,6-dihydro-2H-pyrrolo[3,4-d]pyridazine-1,4-dione
5,7-di-2-thienyl-2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione化学式
CAS
1415304-05-0
化学式
C14H9N3O2S2
mdl
——
分子量
315.376
InChiKey
PVUVHHZLZXIIRH-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    21
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    131
  • 氢给体数:
    3
  • 氢受体数:
    4

反应信息

  • 作为产物:
    参考文献:
    名称:
    化学发光原的原子工程:2,3-二氢-吡咯并[3,4-d]哒嗪-1,4-二酮骨架的合成,性质和聚合。
    摘要:
    两种含有2,5-二(噻吩-2-基)吡咯和哒嗪单元的化学发光化合物,即5,7-二(噻吩-2-基)-2,3-二氢-1H-吡咯并[3,4-d ]哒嗪-1,4(6H)-二酮(5)和6-苯基-5,7-二(噻吩-2-基)-2,3-二氢-1H-吡咯并[3,4-d]哒嗪- 1,4(6H)-二酮(6)已成功合成并进行了电化学聚合。该化合物具有化学发光特性,并在碱性介质中过氧化氢的存在下发光。通过使用Fe 3+离子,血红素(1.0 ppm)或血液样本(1.0 ppm)作为催化剂,可以大大提高辉光的强度。化合物5和6与Ag / AgCl相比,在1.08 V和1.33 V处有一个明确定义的不可逆氧化峰。通过在BF 3的存在下重复电势扫描,成功地进行了5和6的电化学聚合。溶于乙腈的0.1 M LiClO 4电解质溶液中的Et2O 。发现聚合物P5和P6的电子带隙(E g)分别为2.02eV和2.16eV。另一方面,
    DOI:
    10.1007/s10895-016-1978-x
点击查看最新优质反应信息

文献信息

  • Incorporation of a 2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione unit into a donor–acceptor triad: synthesis and ion recognition features
    作者:Melek Pamuk、Fatih Algi
    DOI:10.1016/j.tetlet.2012.10.082
    日期:2012.12
    A novel directly-linked donor-acceptor-donor (D-A-D) type system, which is based on 2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione as the A unit and thiophene as the D units, respectively, is designed, synthesized, and characterized by spectroscopic methods. This novel D-A-D system can be used for the fluorogenic detection of Cu2+ among other ions. (C) 2012 Elsevier Ltd. All rights reserved.
  • Atomistic Engineering of Chemiluminogens: Synthesis, Properties and Polymerization of 2,3-Dihydro-Pyrrolo[3,4-d]Pyridazine-1,4-Dione Scaffolds
    作者:Melek Pamuk Algi、Zahide Oztas、Seha Tirkeş、Atilla Cihaner、Fatih Algi
    DOI:10.1007/s10895-016-1978-x
    日期:2017.3
    chemiluminescent compounds containing 2,5-di(thien-2-yl)pyrrole and pyridazine units, namely 5,7-di(thiophen-2-yl)-2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione (5) and 6-phenyl-5,7-di(thiophen-2-yl)-2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione (6), were successfully synthesized and electrochemically polymerized. The compounds have chemiluminescent properties and glow in the presence of hydrogen
    两种含有2,5-二(噻吩-2-基)吡咯和哒嗪单元的化学发光化合物,即5,7-二(噻吩-2-基)-2,3-二氢-1H-吡咯并[3,4-d ]哒嗪-1,4(6H)-二酮(5)和6-苯基-5,7-二(噻吩-2-基)-2,3-二氢-1H-吡咯并[3,4-d]哒嗪- 1,4(6H)-二酮(6)已成功合成并进行了电化学聚合。该化合物具有化学发光特性,并在碱性介质中过氧化氢的存在下发光。通过使用Fe 3+离子,血红素(1.0 ppm)或血液样本(1.0 ppm)作为催化剂,可以大大提高辉光的强度。化合物5和6与Ag / AgCl相比,在1.08 V和1.33 V处有一个明确定义的不可逆氧化峰。通过在BF 3的存在下重复电势扫描,成功地进行了5和6的电化学聚合。溶于乙腈的0.1 M LiClO 4电解质溶液中的Et2O 。发现聚合物P5和P6的电子带隙(E g)分别为2.02eV和2.16eV。另一方面,
查看更多

同类化合物

5,6,7-三甲基-2,6-二氢-1H-吡咯并[3,4-d]吡嗪-1-酮 1-氯-5,6,7-三甲基-6H-吡咯并[3,4-d]吡嗪盐酸盐 4-(5,7-dimethyl-1-oxo-2-phenyl-1H-pyrrolo[3,4-d]pyridazin-6(2H)-yl)butanoic acid 2,6-dihydro-2-methyl-4-(2-methylpropyl)-6-phenylmethyl-1H-pyrrolo[3,4-d]pyridazin-1-one 1-chloro-4-ethoxy-5,6,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine 1,4-dichloro-5,6,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine 1,4-dichloro-6-isopropyl-6H-pyrrolo[3,4-d]pyridazine ethyl 4-(3-chloro-4-(3-fluorobenzyloxy)phenylamino)-7-methyl-6H-pyrrolo[3,4-d]pyridazine-5-carboxylate 1,2-dihydro-5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine-1-one 1,2-dihydro-2,5,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine-1-one 1-ethoxy-5,6,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine 2,8-dichloro-6-methylpyrrolo<1,2-b:3,4-d'>dipyridazin-5(6H)-one 5,6,7-trimethyl-6H-pyrrolo<3,4-d>pyridazine 1,4,5,7-tetramethyl-6H-pyrrolo[3,4-d]pyridazine 1,4,5,7-tetramethyl-pyrrolo[3,4-d]pyridazin-6-ylamine 5,7-di-2-thienyl-2,3-dihydro-1H-pyrrolo[3,4-d]pyridazine-1,4(6H)-dione 2,3-dihydro-6H-pyrrolo[3,4-d]pyridazine-1,4-dione 5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine 1,2,3,4-tetrahydro-5,7-dimethyl-6H-pyrrolo<3,4-d>pyridazine-1,4-dione 5,10-Dihydro-2,3-dimethoxypyridazino<4',5':3,4>pyrrolo<2,1-a>isochinolin-9(6H)-on 6-Butyl-4-hydroxy-2,5,7-trimethyl-2,6-dihydro-pyrrolo[3,4-d]pyridazin-1-one 4-{5,7-Dimethyl-1-oxo-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-6-YL}-N-(propan-2-YL)butanamide 2-{6-[(4-Fluorophenyl)methyl]-5,7-dimethyl-1-oxo-1H,2H,6H-pyrrolo[3,4-D]pyridazin-2-YL}-N-(4-methylcyclohexyl)acetamide N-[3-(Azepan-1-YL)propyl]-2-{5,7-dimethyl-6-[(4-methylphenyl)methyl]-1-oxo-1H,2H,6H-pyrrolo[3,4-D]pyridazin-2-YL}acetamide N-[2-(Cyclohex-1-EN-1-YL)ethyl]-4-{5,7-dimethyl-1-oxo-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-6-YL}butanamide (6E)-2-methoxy-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 8-chloro-6-methyl-2-(4-methylpiperidin-1-yl)pyrrolo[1,2-b:3,4-d']dipyridazin-5(6H)-one 6-(5-Ethoxypyrazin-2-yl)-1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazine 4,5-dimethoxy-N-phenylmethoxy-10,14,15-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(17),2,4,6,11,13,15-heptaen-13-amine;hydrochloride 6-[4-(4-Ethylpiperazin-1-YL)-4-oxobutyl]-5,7-dimethyl-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-1-one N-benzyl-4-(5,7-dimethyl-4-oxo-3-phenylpyrrolo[3,4-d]pyridazin-6-yl)-N-methylbutanamide 6-[(1S)-1-(4-methoxyphenyl)ethyl]-1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazine 6-[(4-fluorophenyl)methyl]-5,7-dimethyl-2H-pyrrolo[3,4-d]pyridazin-1-one 4,5-dimethoxy-N-phenylmethoxy-10,14,15-triazatetracyclo[8.7.0.02,7.012,17]heptadeca-1(17),2,4,6,11,13,15-heptaen-13-amine 4-(phenylhydrazinylidene)-2-[(Z)-(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)iminomethyl]cyclohexa-2,5-dien-1-one 4-(phenylhydrazinylidene)-2-[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)iminomethyl]cyclohexa-2,5-dien-1-one 2,4-dibromo-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 4-chloro-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 2-methoxy-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 4-bromo-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 2,4-dichloro-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 2-prop-2-enyl-6-[[(1,4,5,7-tetramethylpyrrolo[3,4-d]pyridazin-6-yl)amino]methylidene]cyclohexa-2,4-dien-1-one 6-[1-(4-ethylpiperazin-1-yl)-1-oxopropan-2-yl]-5,7-dimethyl-2-phenyl-1H,2H,6H-pyrrolo[3,4-d]pyridazin-1-one 2-{5,7-Dimethyl-1-oxo-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-6-YL}-N-[(2-ethoxyphenyl)methyl]acetamide 2-(5,7-dimethyl-4-oxo-3-phenylpyrrolo[3,4-d]pyridazin-6-yl)-N-methylpropanamide 2-(6-benzyl-5,7-dimethyl-4-oxopyrrolo[3,4-d]pyridazin-3-yl)-N-methylacetamide 4-{5,7-Dimethyl-1-oxo-2-phenyl-1H,2H,6H-pyrrolo[3,4-D]pyridazin-6-YL}-N-(2-phenylethyl)butanamide 2-(5,7-dimethyl-4-oxo-3-phenylpyrrolo[3,4-d]pyridazin-6-yl)-N-propan-2-ylacetamide N,N-Diethyl-2-{6-[(2-fluorophenyl)methyl]-5,7-dimethyl-1-oxo-1H,2H,6H-pyrrolo[3,4-D]pyridazin-2-YL}acetamide